T-54

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameT-54
Drug Alias Nameetoposide derivative (Matrix)T-54
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTopoisomerase II inhibitors
TargetsTopoisomerase II
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMatrix Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMatrix Therapeutics
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A